|
[1]. Love, J. C.; Estroff, L. A.; Kriebel, J. K.; Nuzzo, R. G.; Whitesides, G. M., Self-Assembled Monolayers of Thiolates on Metals as a Form of Nanotechnology. Chem. Rev. 2005, 105, 1103-1170. [2]. Suh, W. H.; Suslick, K. S.; Stucky, G. D.; Suh, Y. H., Nanotechnology, nanotoxicology, and neuroscience. Prog. Neurobiol. 2009, 87, 133-70. [3]. Weissleder, R., Molecular Imaging in Cancer. Science 2006, 312, 1168-1171. [4]. Nam, J.; Won, N.; Bang, J.; Jin, H.; Park, J.; Jung, S.; Park, Y.; Kim, S., Surface engineering of inorganic nanoparticles for imaging and therapy. Adv. Drug Deliver. Rev. 2012. [5]. (a) Link, S.; El-Sayed, M. A., Shape and size dependence of radiative, non-radiative and photothermal properties of gold nanocrystals. Int. Rev. Phy. Chem. 2000, 19, 409-453; (b) Dreaden, E. C.; Alkilany, A. M.; Huang, X.; Murphy, C. J.; El-Sayed, M. A., The golden age: gold nanoparticles for biomedicine. Chem. Soc. Rev. 2012, 41, 2740-2779. [6]. Jain, P. K.; El-Sayed, I. H.; El-Sayed, M. A., Au nanoparticles target cancer. Nano Today 2007, 2, 18-29. [7]. Kelly, K. L.; Coronado, E.; Zhao, L. L.; Schatz, G. C., The Optical Properties of Metal Nanoparticles: The Influence of Size, Shape, and Dielectric Environment. J. Phys. Chem. B 2002, 107, 668-677. [8]. Hayat, M., Colloidal Gold: Principles, Methods and Applications. Academic Press: San Diego, CA, 1989. [9]. Nie, S.; Emory, S. R., Probing Single Molecules and Single Nanoparticles by Surface-Enhanced Raman Scattering. Science 1997, 275, 1102-1106. [10]. Sokolov, K.; Aaron, J.; Hsu, B.; Nida, D.; Gillenwater, A.; Follen, M.; MacAulay, C.; Adler-Storthz, K.; Korgel, B.; Descour, M., et al., Optical systems for in vivo molecular imaging of cancer. Technol. Cancer Res. Treat. 2003, 2, 491-504. [11]. (a) Hermanson, G. T., Bioconjugate Techniques. Academic Press: San Diego, CA, 1996; (b) Sokolov, K.; Follen, M.; Aaron, J.; Pavlova, I.; Malpica, A.; Lotan, R.; Richards-Kortum, R., Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles. Cancer Res. 2003, 63, 1999-2004. [12]. (a) Yelin, D.; Oron, D.; Thiberge, S.; Moses, E.; Silberberg, Y., Multiphoton plasmon-resonance microscopy. Opt. Express 2003, 11, 1385-1391; (b) El-Sayed, I. H.; Huang, X.; El-Sayed, M. A., Surface Plasmon Resonance Scattering and Absorption of anti-EGFR Antibody Conjugated Gold Nanoparticles in Cancer Diagnostics: Applications in Oral Cancer. Nano Lett. 2005, 5, 829-834. [13]. (a) Connor, E. E.; Mwamuka, J.; Gole, A.; Murphy, C. J.; Wyatt, M. D., Gold Nanoparticles Are Taken Up by Human Cells but Do Not Cause Acute Cytotoxicity. Small 2005, 1, 325-327; (b) Shukla, R.; Bansal, V.; Chaudhary, M.; Basu, A.; Bhonde, R. R.; Sastry, M., Biocompatibility of Gold Nanoparticles and Their Endocytotic Fate Inside the Cellular Compartment: A Microscopic Overview. Langmuir 2005, 21, 10644-10654. [14]. Daniel, M.-C.; Astruc, D., Gold Nanoparticles: Assembly, Supramolecular Chemistry, Quantum-Size-Related Properties, and Applications toward Biology, Catalysis, and Nanotechnology. Chem. Rev. 2003, 104, 293-346. [15]. Perrault, S. D.; Walkey, C.; Jennings, T.; Fischer, H. C.; Chan, W. C. W., Mediating Tumor Targeting Efficiency of Nanoparticles Through Design. Nano Lett. 2009, 9, 1909-1915. [16]. Rosi, N. L.; Giljohann, D. A.; Thaxton, C. S.; Lytton-Jean, A. K. R.; Han, M. S.; Mirkin, C. A., Oligonucleotide-Modified Gold Nanoparticles for Intracellular Gene Regulation. Science 2006, 312, 1027-1030. [17]. (a) Chithrani, B. D.; Chan, W. C. W., Elucidating the Mechanism of Cellular Uptake and Removal of Protein-Coated Gold Nanoparticles of Different Sizes and Shapes. Nano Lett. 2007, 7, 1542-1550; (b) Giljohann, D. A.; Seferos, D. S.; Patel, P. C.; Millstone, J. E.; Rosi, N. L.; Mirkin, C. A., Oligonucleotide Loading Determines Cellular Uptake of DNA-Modified Gold Nanoparticles. Nano Lett. 2007, 7, 3818-3821; (c) Jiang, W.; KimBetty, Y. S.; Rutka, J. T.; ChanWarren, C. W., Nanoparticle-mediated cellular response is size-dependent. Nat. Nanotechnol. 2008, 3, 145-150. [18]. (a) Ghosh, P.; Han, G.; De, M.; Kim, C. K.; Rotello, V. M., Gold nanoparticles in delivery applications. Adv. Drug Deliver. Rev. 2008, 60, 1307-1315; (b) Kim, C.-k.; Ghosh, P.; Rotello, V. M., Multimodal drug delivery using gold nanoparticles. Nanoscale 2009, 1, 61-67. [19]. Rana, S.; Bajaj, A.; Mout, R.; Rotello, V. M., Monolayer coated gold nanoparticles for delivery applications. Adv. Drug Deliver. Rev. 2012, 64, 200-216. [20]. Hostetler, M. J.; Wingate, J. E.; Zhong, C.-J.; Harris, J. E.; Vachet, R. W.; Clark, M. R.; Londono, J. D.; Green, S. J.; Stokes, J. J.; Wignall, G. D., et al., Alkanethiolate Gold Cluster Molecules with Core Diameters from 1.5 to 5.2 nm: Core and Monolayer Properties as a Function of Core Size. Langmuir 1998, 14, 17-30. [21]. Gibson, J. D.; Khanal, B. P.; Zubarev, E. R., Paclitaxel-Functionalized Gold Nanoparticles. J. Am. Chem. Soc. 2007, 129, 11653-11661. [22]. Aryal, S.; Grailer, J. J.; Pilla, S.; Steeber, D. A.; Gong, S., Doxorubicin conjugated gold nanoparticles as water-soluble and pH-responsive anticancer drug nanocarriers. J. Mater. Chem. 2009, 19, 7879-7884. [23]. Ellington, A. D.; Szostak, J. W., In vitro selection of RNA molecules that bind specific ligands. Nature 1990, 346, 818-822. [24]. Tuerk, C.; Gold, L., Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990, 249, 505-10. [25]. Hamula, C. L. A.; Guthrie, J. W.; Zhang, H.; Li, X.-F.; Le, X. C., Selection and analytical applications of aptamers. Trac - Trends Anal. Chem. 2006, 25, 681-691. [26]. Guo, K. T.; Ziemer, G.; Paul, A.; Wendel, H. P., CELL-SELEX: Novel perspectives of aptamer-based therapeutics. Int. J. Mol. Sci. 2008, 9, 668-78. [27]. (a) Shamah, S. M.; Healy, J. M.; Cload, S. T., Complex Target SELEX. Accounts Chem. Res. 2008, 41, 130-138; (b) Phillips, J. A.; Lopez-Colon, D.; Zhu, Z.; Xu, Y.; Tan, W., Applications of aptamers in cancer cell biology. Anal. Chim. Acta 2008, 621, 101-8. [28]. Shangguan, D.; Li, Y.; Tang, Z.; Cao, Z. C.; Chen, H. W.; Mallikaratchy, P.; Sefah, K.; Yang, C. J.; Tan, W., Aptamers evolved from live cells as effective molecular probes for cancer study. Proc. Natl. Acad. Sci. U. S. A. 2006, 103, 11838-11843. [29]. Lee, J. O.; So, H. M.; Jeon, E. K.; Chang, H.; Won, K.; Kim, Y. H., Aptamers as molecular recognition elements for electrical nanobiosensors. Anal. Bioanal. Chem. 2008, 390, 1023-32. [30]. Minotti, G.; Menna, P.; Salvatorelli, E.; Cairo, G.; Gianni, L., Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity. Pharmacol. Rev. 2004, 56, 185-229. [31]. Zhu, G.; Ye, M.; Donovan, M. J.; Song, E.; Zhao, Z.; Tan, W., Nucleic acid aptamers: an emerging frontier in cancer therapy. Chem. Commun. 2012, 48, 10472-10480. [32]. Bagalkot, V.; Farokhzad, O. C.; Langer, R.; Jon, S., An Aptamer–Doxorubicin Physical Conjugate as a Novel Targeted Drug-Delivery Platform. Angew. Chem. Int. Edit. 2006, 45, 8149-8152. [33]. Huang, Y. F.; Shangguan, D.; Liu, H.; Phillips, J. A.; Zhang, X.; Chen, Y.; Tan, W., Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells. ChemBioChem 2009, 10, 862-8. [34]. Wang, H.; Yang, R.; Yang, L.; Tan, W., Nucleic Acid Conjugated Nanomaterials for Enhanced Molecular Recognition. ACS Nano 2009, 3, 2451-2460. [35]. Yang, L.; Zhang, X.; Ye, M.; Jiang, J.; Yang, R.; Fu, T.; Chen, Y.; Wang, K.; Liu, C.; Tan, W., Aptamer-conjugated nanomaterials and their applications. Adv. Drug Deliver. Rev. 2011, 63, 1361-1370. [36]. Huang, C.-C.; Huang, Y.-F.; Cao, Z.; Tan, W.; Chang, H.-T., Aptamer-Modified Gold Nanoparticles for Colorimetric Determination of Platelet-Derived Growth Factors and Their Receptors. Anal. Chem. 2005, 77, 5735-5741. [37]. Medley, C. D.; Smith, J. E.; Tang, Z.; Wu, Y.; Bamrungsap, S.; Tan, W., Gold nanoparticle-based colorimetric assay for the direct detection of cancerous cells. Anal. Chem. 2008, 80, 1067-72. [38]. Sapsford, K. E.; Algar, W. R.; Berti, L.; Gemmill, K. B.; Casey, B. J.; Oh, E.; Stewart, M. H.; Medintz, I. L., Functionalizing nanoparticles with biological molecules: developing chemistries that facilitate nanotechnology. Chem. Rev. 2013, 113, 1904-2074. [39]. Sailor, M. J.; Park, J.-H., Hybrid Nanoparticles for Detection and Treatment of Cancer. Adv. Mater. 2012, 24, 3779-3802. [40]. Simovic, S.; Barnes, T. J.; Tan, A.; Prestidge, C. A., Assembling nanoparticle coatings to improve the drug delivery performance of lipid based colloids. Nanoscale 2012, 4, 1220-1230. [41]. (a) Preiss, M. R.; Bothun, G. D., Stimuli-responsive liposome-nanoparticle assemblies. Expert Opin. Drug Deliv. 2011, 8, 1025-1040; (b) Al-Jamal, W. T.; Kostarelos, K., Liposomes: From a Clinically Established Drug Delivery System to a Nanoparticle Platform for Theranostic Nanomedicine. Accounts Chem. Res. 2011, 44, 1094-1104; (c) Yang, J. A.; Murphy, C. J., Evidence for Patchy Lipid Layers on Gold Nanoparticle Surfaces. Langmuir 2012, 28, 5404-5416. [42]. Rasch, M. R.; Rossinyol, E.; Hueso, J. L.; Goodfellow, B. W.; Arbiol, J.; Korgel, B. A., Hydrophobic Gold Nanoparticle Self-Assembly with Phosphatidylcholine Lipid: Membrane-Loaded and Janus Vesicles. Nano Lett. 2010, 10, 3733-3739. [43]. Haeng Sub, W.; Kyuyong, L.; Hyuk Kyu, P., Interfacial energy consideration in the organization of a quantum dot–lipid mixed system. J. Phys.-Condes. Matter 2008, 20, 494211. [44]. (a) Paasonen, L.; Laaksonen, T.; Johans, C.; Yliperttula, M.; Kontturi, K.; Urtti, A., Gold nanoparticles enable selective light-induced contents release from liposomes. J. Control. Release 2007, 122, 86-93; (b) Paasonen, L.; Sipilä, T.; Subrizi, A.; Laurinmäki, P.; Butcher, S. J.; Rappolt, M.; Yaghmur, A.; Urtti, A.; Yliperttula, M., Gold-embedded photosensitive liposomes for drug delivery: Triggering mechanism and intracellular release. J. Control. Release 2010, 147, 136-143. [45]. Wu, G.; Mikhailovsky, A.; Khant, H. A.; Fu, C.; Chiu, W.; Zasadzinski, J. A., Remotely Triggered Liposome Release by Near-Infrared Light Absorption via Hollow Gold Nanoshells. J. Am. Chem. Soc. 2008, 130, 8175-8177. [46]. Luthi, A. J.; Zhang, H.; Kim, D.; Giljohann, D. A.; Mirkin, C. A.; Thaxton, C. S., Tailoring of Biomimetic High-Density Lipoprotein Nanostructures Changes Cholesterol Binding and Efflux. ACS Nano 2011, 6, 276-285. [47]. Pradhan, P.; Giri, J.; Rieken, F.; Koch, C.; Mykhaylyk, O.; Döblinger, M.; Banerjee, R.; Bahadur, D.; Plank, C., Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy. J. Control. Release 2010, 142, 108-121. [48]. Sitaula, S.; Mackiewicz, M. R.; Reed, S. M., Gold nanoparticles become stable to cyanide etch when coated with hybrid lipid bilayers. Chem. Commun. 2008, 0, 3013-3015. [49]. Jin, Q.; Xu, J.-P.; Ji, J.; Shen, J.-C., Zwitterionic phosphorylcholine as a better ligand for stabilizing large biocompatible gold nanoparticles. Chem. Commun. 2008, 0, 3058-3060. [50]. Tam, N. C. M.; Scott, B. M. T.; Voicu, D.; Wilson, B. C.; Zheng, G., Facile Synthesis of Raman Active Phospholipid Gold Nanoparticles. Bioconjugate Chem. 2010, 21, 2178-2182. [51]. Ip, S.; MacLaughlin, C. M.; Gunari, N.; Walker, G. C., Phospholipid Membrane Encapsulation of Nanoparticles for Surface-Enhanced Raman Scattering. Langmuir 2011, 27, 7024-7033. [52]. Tam, N. C. M.; McVeigh, P. Z.; MacDonald, T. D.; Farhadi, A.; Wilson, B. C.; Zheng, G., Porphyrin–Lipid Stabilized Gold Nanoparticles for Surface Enhanced Raman Scattering Based Imaging. Bioconjugate Chem. 2012, 23, 1726-1730. [53]. Nel, A. E.; Madler, L.; Velegol, D.; Xia, T.; Hoek, E. M. V.; Somasundaran, P.; Klaessig, F.; Castranova, V.; Thompson, M., Understanding biophysicochemical interactions at the nano-bio interface. Nat. Mater. 2009, 8, 543-557. [54]. Verma, A.; Uzun, O.; Hu, Y.; Hu, Y.; Han, H.-S.; Watson, N.; Chen, S.; Irvine, D. J.; Stellacci, F., Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles. Nat. Mater. 2008, 7, 588-595. [55]. (a) Zhou, W.; Shao, J.; Jin, Q.; Wei, Q.; Tang, J.; Ji, J., Zwitterionic phosphorylcholine as a better ligand for gold nanorods cell uptake and selective photothermal ablation of cancer cells. Chem. Commun. 2010, 46, 1479-1481; (b) Eliyahu, G.; Kreizman, T.; Degani, H., Phosphocholine as a biomarker of breast cancer: Molecular and biochemical studies. Int. J. Cancer 2007, 120, 1721-1730. [56]. Leroueil, P. R.; Hong, S.; Mecke, A.; Baker, J. R.; Orr, B. G.; Banaszak Holl, M. M., Nanoparticle Interaction with Biological Membranes: Does Nanotechnology Present a Janus Face? Accounts Chem. Res. 2007, 40, 335-342. [57]. Fleige, E.; Quadir, M. A.; Haag, R., Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: Concepts and applications. Adv. Drug Deliver. Rev. 2012, 64, 866-884. [58]. Gao, W.; Chan, J. M.; Farokhzad, O. C., pH-Responsive Nanoparticles for Drug Delivery. Mol. Pharm. 2010, 7, 1913-1920. [59]. Rajput, G.; Majmudar, F.; Patel, J.; Thakor, R.; Rajgor, N. B., Stomach-specific mucoadhesive microsphere as a controlled drug delivery system. Syst. Rev. Pharm. 2010, 1, 70. [60]. Gerweck, L. E.; Vijayappa, S.; Kozin, S., Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics. Mol. Cancer Ther. 2006, 5, 1275-9. [61]. Whitehead, K. A.; Langer, R.; Anderson, D. G., Knocking down barriers: advances in siRNA delivery. Nat. Rev. Drug Discov. 2009, 8, 129-138. [62]. (a) Yamanaka, Y. J.; Leong, K. W., Engineering strategies to enhance nanoparticle-mediated oral delivery. J. Biomater. Sci.-Polym. Ed. 2008, 19, 1549-70; (b) Morishita, M.; Peppas, N. A., Is the oral route possible for peptide and protein drug delivery? Drug Discov. Today 2006, 11, 905-10. [63]. Colombo, P.; Sonvico, F.; Colombo, G.; Bettini, R., Novel platforms for oral drug delivery. Pharm. Res. 2009, 26, 601-11. [64]. Lee, C.-H.; Lo, L.-W.; Mou, C.-Y.; Yang, C.-S., Synthesis and Characterization of Positive-Charge Functionalized Mesoporous Silica Nanoparticles for Oral Drug Delivery of an Anti-Inflammatory Drug. Adv. Funct. Mater. 2008, 18, 3283-3292. [65]. (a) Vaupel, P., Tumor microenvironmental physiology and its implications for radiation oncology. Semin. Radiat. Oncol. 2004, 14, 198-206; (b) Vaupel, P.; Kallinowski, F.; Okunieff, P., Blood Flow, Oxygen and Nutrient Supply, and Metabolic Microenvironment of Human Tumors: A Review. Cancer Res. 1989, 49, 6449-6465. [66]. Kim, J.-w.; Dang, C. V., Cancer's Molecular Sweet Tooth and the Warburg Effect. Cancer Res. 2006, 66, 8927-8930. [67]. Christofk, H. R.; Vander Heiden, M. G.; Harris, M. H.; Ramanathan, A.; Gerszten, R. E.; Wei, R.; Fleming, M. D.; Schreiber, S. L.; Cantley, L. C., The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 2008, 452, 230-233. [68]. Brahimi-Horn, M. C.; Pouyssegur, J., Oxygen, a source of life and stress. FEBS Lett. 2007, 581, 3582-91. [69]. Aryal, S.; Hu, C.-M. J.; Zhang, L., Polymer−Cisplatin Conjugate Nanoparticles for Acid-Responsive Drug Delivery. ACS Nano 2009, 4, 251-258. [70]. Murphy, R. F.; Powers, S.; Cantor, C. R., Endosome pH measured in single cells by dual fluorescence flow cytometry: rapid acidification of insulin to pH 6. J. Cell Biol. 1984, 98, 1757-62. [71]. Behr, J.-P., The Proton Sponge: a Trick to Enter Cells the Viruses Did Not Exploit. Chimia 1997, 51, 34-36. [72]. Hoon Jeong, J.; Christensen, L. V.; Yockman, J. W.; Zhong, Z.; Engbersen, J. F.; Jong Kim, W.; Feijen, J.; Wan Kim, S., Reducible poly(amido ethylenimine) directed to enhance RNA interference. Biomaterials 2007, 28, 1912-7. [73]. Weissleder, R., A clearer vision for in vivo imaging. Nat. Biotechnol. 2001, 19, 316-317. [74]. Kang, H.; Trondoli, A. C.; Zhu, G.; Chen, Y.; Chang, Y.-J.; Liu, H.; Huang, Y.-F.; Zhang, X.; Tan, W., Near-Infrared Light-Responsive Core–Shell Nanogels for Targeted Drug Delivery. ACS Nano 2011, 5, 5094-5099. [75]. Triesscheijn, M.; Baas, P.; Schellens, J. H. M.; Stewart, F. A., Photodynamic Therapy in Oncology. Oncologist 2006, 11, 1034-1044. [76]. Hatz, S.; Lambert, J. D. C.; Ogilby, P. R., Measuring the lifetime of singlet oxygen in a single cell: addressing the issue of cell viability. Photochem. Photobio. Sci. 2007, 6, 1106-1116. [77]. Chatterjee, D. K.; Fong, L. S.; Zhang, Y., Nanoparticles in photodynamic therapy: an emerging paradigm. Adv. Drug Deliver. Rev. 2008, 60, 1627-37. [78]. Selbo, P. K.; Weyergang, A.; Hogset, A.; Norum, O. J.; Berstad, M. B.; Vikdal, M.; Berg, K., Photochemical internalization provides time- and space-controlled endolysosomal escape of therapeutic molecules. J. Control. Release 2010, 148, 2-12. [79]. Lehner, R.; Wang, X.; Wolf, M.; Hunziker, P., Designing switchable nanosystems for medical application. J. Control. Release 2012, 161, 307-16. [80]. Seyfried, T. N.; Shelton, L. M., Cancer as a metabolic disease. Nutr. Metab. 2010, 7, 7. [81]. Anand, P.; Kunnumakkara, A. B.; Sundaram, C.; Harikumar, K. B.; Tharakan, S. T.; Lai, O. S.; Sung, B.; Aggarwal, B. B., Cancer is a preventable disease that requires major lifestyle changes. Pharm. Res. 2008, 25, 2097-116. [82]. Siegel, R.; Naishadham, D.; Jemal, A., Cancer statistics, 2012. CA-Cancer J. Clin. 2012, 62, 10-29. [83]. Siegel, R.; DeSantis, C.; Virgo, K.; Stein, K.; Mariotto, A.; Smith, T.; Cooper, D.; Gansler, T.; Lerro, C.; Fedewa, S., et al., Cancer treatment and survivorship statistics, 2012. CA-Cancer J. Clin. 2012, 62, 220-241. [84]. Upadhyay, K. K.; Bhatt, A. N.; Mishra, A. K.; Dwarakanath, B. S.; Jain, S.; Schatz, C.; Le Meins, J.-F.; Farooque, A.; Chandraiah, G.; Jain, A. K., et al., The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(γ-benzyl l-glutamate)-b-hyaluronan polymersomes. Biomaterials 2010, 31, 2882-2892. [85]. Susa, M.; Iyer, A. K.; Ryu, K.; Hornicek, F. J.; Mankin, H.; Amiji, M. M.; Duan, Z., Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcoma. BMC Cancer 2009, 9, 399. [86]. Devy, L.; de Groot, F. M.; Blacher, S.; Hajitou, A.; Beusker, P. H.; Scheeren, H. W.; Foidart, J. M.; Noel, A., Plasmin-activated doxorubicin prodrugs containing a spacer reduce tumor growth and angiogenesis without systemic toxicity. FASEB J. 2004, 18, 565-7. [87]. Zhang, X.; Chibli, H.; Mielke, R.; Nadeau, J., Ultrasmall Gold−Doxorubicin Conjugates Rapidly Kill Apoptosis-Resistant Cancer Cells. Bioconjugate Chem. 2010, 22, 235-243. [88]. Allen, T. M.; Cullis, P. R., Drug Delivery Systems: Entering the Mainstream. Science 2004, 303, 1818-1822. [89]. Ferrari, M., Cancer nanotechnology: opportunities and challenges. Nat. Rev. Cancer 2005, 5, 161-171. [90]. Farokhzad, O. C.; Langer, R., Impact of Nanotechnology on Drug Delivery. ACS Nano 2009, 3, 16-20. [91]. Tiwari, P.; Vig, K.; Dennis, V.; Singh, S., Functionalized Gold Nanoparticles and Their Biomedical Applications. Nanomaterials 2011, 1, 31-63. [92]. Gao, Z.; Zhang, L.; Sun, Y., Nanotechnology applied to overcome tumor drug resistance. J. Control. Release 2012, 162, 45-55. [93]. Parhi, P.; Mohanty, C.; Sahoo, S. K., Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy. Drug Discov. Today 2012, 17, 1044-1052. [94]. Mahato, R.; Tai, W.; Cheng, K., Prodrugs for improving tumor targetability and efficiency. Adv. Drug Deliver. Rev. 2011, 63, 659-670. [95]. (a) Yamashita, F.; Hashida, M., Pharmacokinetic considerations for targeted drug delivery. Adv. Drug Deliver. Rev. 2013, 65, 139-147; (b) Bildstein, L.; Dubernet, C.; Couvreur, P., Prodrug-based intracellular delivery of anticancer agents. Adv. Drug Deliver. Rev. 2011, 63, 3-23. [96]. Kratz, F., Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles. J. Control. Release 2008, 132, 171-83. [97]. Kratz, F.; Warnecke, A., Finding the optimal balance: Challenges of improving conventional cancer chemotherapy using suitable combinations with nano-sized drug delivery systems. J. Control. Release 2012, 164, 221-235. [98]. Conner, S. D.; Schmid, S. L., Regulated portals of entry into the cell. Nature 2003, 422, 37-44. [99]. (a) Park, J.; Nam, J.; Won, N.; Jin, H.; Jung, S.; Jung, S.; Cho, S.-H.; Kim, S., Compact and Stable Quantum Dots with Positive, Negative, or Zwitterionic Surface: Specific Cell Interactions and Non-Specific Adsorptions by the Surface Charges. Adv. Funct. Mater. 2011, 21, 1558-1566; (b) Krpetić, Ž.; Nativo, P.; Prior, I. A.; Brust, M., Acrylate-Facilitated Cellular Uptake of Gold Nanoparticles. Small 2011, 7, 1982-1986. [100]. (a) Chithrani, B. D.; Ghazani, A. A.; Chan, W. C. W., Determining the Size and Shape Dependence of Gold Nanoparticle Uptake into Mammalian Cells. Nano Lett. 2006, 6, 662-668; (b) Zhang, S.; Li, J.; Lykotrafitis, G.; Bao, G.; Suresh, S., Size-Dependent Endocytosis of Nanoparticles. Adv. Mater. 2009, 21, 419-424; (c) Wang, S. H.; Lee, C. W.; Chiou, A.; Wei, P. K., Size-dependent endocytosis of gold nanoparticles studied by three-dimensional mapping of plasmonic scattering images. J. Nanobiotechnology 2010, 8, 33. [101]. Nam, J.; Won, N.; Jin, H.; Chung, H.; Kim, S., pH-Induced Aggregation of Gold Nanoparticles for Photothermal Cancer Therapy. J. Am. Chem. Soc. 2009, 131, 13639-13645. [102]. (a) Sonavane, G.; Tomoda, K.; Makino, K., Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Colloid Surf. B-Biointerfaces 2008, 66, 274-80; (b) De Jong, W. H.; Hagens, W. I.; Krystek, P.; Burger, M. C.; Sips, A. J.; Geertsma, R. E., Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 2008, 29, 1912-9. [103]. Peer, D.; Karp, J. M.; Hong, S.; Farokhzad, O. C.; Margalit, R.; Langer, R., Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2007, 2, 751-760. [104]. Wu, Y.; Sefah, K.; Liu, H.; Wang, R.; Tan, W., DNA aptamer–micelle as an efficient detection/delivery vehicle toward cancer cells. Proc. Natl. Acad. Sci. U. S. A. 2010, 107, 5-10. [105]. Bae, Y. H.; Park, K., Targeted drug delivery to tumors: myths, reality and possibility. J. Control. Release 2011, 153, 198-205. [106]. Kaneko, T.; Willner, D.; Monkovic, I.; Knipe, J. O.; Braslawsky, G. R.; Greenfield, R. S.; Vyas, D. M., New hydrazone derivatives of Adriamycin and their immunoconjugates - a correlation between acid stability and cytotoxicity. Bioconjugate Chem. 1991, 2, 133-141. [107]. Hamid, R.; Rotshteyn, Y.; Rabadi, L.; Parikh, R.; Bullock, P., Comparison of alamar blue and MTT assays for high through-put screening. Toxicol. Vitro 2004, 18, 703-710. [108]. Ohkuma, S.; Poole, B., Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proc. Natl. Acad. Sci. U. S. A. 1978, 75, 3327-31. [109]. Huang, Y.-F.; Shangguan, D.; Liu, H.; Phillips, J. A.; Zhang, X.; Chen, Y.; Tan, W., Molecular Assembly of an Aptamer–Drug Conjugate for Targeted Drug Delivery to Tumor Cells. ChemBioChem 2009, 10, 862-868. [110]. (a) Liu, X.; Atwater, M.; Wang, J.; Huo, Q., Extinction coefficient of gold nanoparticles with different sizes and different capping ligands. Colloid Surf. B-Biointerfaces 2007, 58, 3-7; (b) Huo, F.; Lytton-Jean, A. K. R.; Mirkin, C. A., Asymmetric Functionalization of Nanoparticles Based on Thermally Addressable DNA Interconnects. Adv. Mater. 2006, 18, 2304-2306. [111]. Hurst, S. J.; Lytton-Jean, A. K. R.; Mirkin, C. A., Maximizing DNA Loading on a Range of Gold Nanoparticle Sizes. Anal. Chem. 2006, 78, 8313-8318. [112]. Nam, J.; La, W.-G.; Hwang, S.; Ha, Y. S.; Park, N.; Won, N.; Jung, S.; Bhang, S. H.; Ma, Y.-J.; Cho, Y.-M., et al., pH-Responsive Assembly of Gold Nanoparticles and “Spatiotemporally Concerted” Drug Release for Synergistic Cancer Therapy. ACS Nano 2013, 7, 3388-3402. [113]. Xiao, Z.; Shangguan, D.; Cao, Z.; Fang, X.; Tan, W., Cell-Specific Internalization Study of an Aptamer from Whole Cell Selection. Chem.-Eur. J. 2008, 14, 1769-1775. [114]. (a) Ahmed, S.; Savarala, S.; Chen, Y.; Bothun, G.; Wunder, S. L., Formation of Lipid Sheaths around Nanoparticle-Supported Lipid Bilayers. Small 2012, 8, 1740-1751; (b) Verma, A.; Stellacci, F., Effect of Surface Properties on Nanoparticle–Cell Interactions. Small 2010, 6, 12-21; (c) Lin, J.; Zhang, H.; Chen, Z.; Zheng, Y., Penetration of Lipid Membranes by Gold Nanoparticles: Insights into Cellular Uptake, Cytotoxicity, and Their Relationship. ACS Nano 2010, 4, 5421-5429. [115]. Kim, B.; Han, G.; Toley, B. J.; Kim, C.-k.; Rotello, V. M.; Forbes, N. S., Tuning payload delivery in tumour cylindroids using gold nanoparticles. Nat. Nanotechnol. 2010, 5, 465-472. [116]. Bae, Y.; Fukushima, S.; Harada, A.; Kataoka, K., Design of Environment-Sensitive Supramolecular Assemblies for Intracellular Drug Delivery: Polymeric Micelles that are Responsive to Intracellular pH Change. Angew. Chem.- Int. Edit. 2003, 42, 4640-4643.
|